EUVIMEDEUVIMED entdecken
Crossref

Genetically Predicted Higher Levels of Caffeic Acid Are Protective Against Ulcerative Colitis: A Comprehensive Metabolome Analysis

Takeo Naito iD, Ryuya Osaka, Yoichi Kakuta iD, Yosuke Kawai, Seik-Soon Khor, Junji Umeno, Katsushi Tokunaga, NCBN Controls WGS Consortium, Hiroshi Nagai, Yusuke Shimoyama, Rintaro Moroi, Hisashi Shiga iD und 3 weitere

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izae143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Takeo Naito und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Metabolome, Polymorphism, Single Nucleotide, Caffeic Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science KAKENHI, Japan Science and Technology Agency NBDC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is crucial to pinpoint the metabolites that cause Crohn’s disease (CD) and ulcerative colitis (UC) to comprehend their pathogenesis and identify possible targets for therapy. To achieve this goal, we performed the first metabolome-wide Mendelian randomization (MR) study of Japanese patients with CD and UC.

Methods

As exposure datasets, genetic instruments with blood-circulating metabolites were obtained from the Tohoku Medical Megabank Organization, which includes 204 metabolites from the genome-wide association study data of 7843 Japanese individuals. As outcome datasets, we enrolled Japanese patients with CD (n = 1803), Japanese patients with UC (n = 1992), and healthy controls (n = 2022). The main analysis utilized the inverse variance–weighted method, while stability of the findings was evaluated through sensitivity analyses.

Results

After single nucleotide polymorphism (SNP) filtering, 169 SNPs for 45 metabolites were available for MR. Genetically predicted elevated circulating trans-glutaconic acid and tryptophan were associated with a lower CD risk (odds ratio [OR], 0.68; P = 5.95 × 10−3; and OR, 0.64; P = 1.90 × 10−2, respectively). Genetically predicted elevated caffeic acid was associated with a lower UC risk (OR, 0.67; P = 4.2 × 10−4), which remained significant after multiple testing correction. We identified a causal link between UC and 3-hydroxybutyrate (OR, 2.21; P = 1.41 × 10−2), trans-glutaconic acid (OR, 0.72; P = 1.77 × 10−2), and 2-hydroxyvaleric acid (OR, 1.31; P = 4.23 × 10−2). There was no evidence of pleiotropy or reverse causal effects for these candidate metabolites.

Conclusions

In our metabolome-wide MR study, we discovered a notable protective effect of caffeic acid against UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeMetabolomePolymorphism, Single NucleotideCaffeic AcidsGenome-Wide Association StudyMendelian Randomization AnalysisHumansMaleFemaleCase-Control StudiesAdultJapanCrohn DiseaseMiddle AgedMetabolomics

Stichwörter der Autor:innen

Crohn’s diseaseJapaneseMendelian randomizationMetabolomeUlcerative colitis

Substanzen

Caffeic Acidscaffeic acid

Autor:innen und Institutionen

  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Genome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
  • Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore.
  • Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Central Biobank, National Center Biobank Network, Tokyo, Japan.
  • Division of Biomedical Information Analysis, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

ORCID-Profile: Takeo Naito, Yoichi Kakuta, Hisashi Shiga

Förderung

  • Japan Society for the Promotion of Science KAKENHI
  • Japan Science and Technology Agency NBDC

Zitieren

APA

Naito, T., Osaka, R., Kakuta, Y., Kawai, Y., Khor, S. S., Umeno, J., Tokunaga, K., NCBN Controls WGS Consortium, Nagai, H., Shimoyama, Y., Moroi, R., Shiga, H., Nagasaki, M., Kinouchi, Y., & Masamune, A. (2024). Genetically Predicted Higher Levels of Caffeic Acid Are Protective Against Ulcerative Colitis: A Comprehensive Metabolome Analysis. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae143

Vancouver

Naito T, Osaka R, Kakuta Y, Kawai Y, Khor SS, Umeno J, et al. Genetically Predicted Higher Levels of Caffeic Acid Are Protective Against Ulcerative Colitis: A Comprehensive Metabolome Analysis. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izae143

BibTeX
@article{Naito2024,
  author = {Naito, Takeo and Osaka, Ryuya and Kakuta, Yoichi and Kawai, Yosuke and Khor, Seik-Soon and Umeno, Junji and Tokunaga, Katsushi and NCBN Controls WGS Consortium, NCBN Controls WGS Consortium and Nagai, Hiroshi and Shimoyama, Yusuke and Moroi, Rintaro and Shiga, Hisashi and Nagasaki, Masao and Kinouchi, Yoshitaka and Masamune, Atsushi},
  title = {Genetically Predicted Higher Levels of Caffeic Acid Are Protective Against Ulcerative Colitis: A Comprehensive Metabolome Analysis},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izae143}
}
Kostenlos starten →